| 摘要 |
<p>The present invention new methods of using proteins markers MAP17 and/or SGLT1, or mRNA encoding these proteins, as indicators for survival after treatment of a human subject suffering from a cancer disease with radiotherapy and/or chemotherapy.</p> |
